Moreover, a histological analysis of tumor sections revealed that the combination of ZC-22 and cisplatin dramatically suppressed the expression of Ki67 and increased the accumulation of γH2A.X (Figure 6D,E), suggesting that it was an effective strategy for the treatment of breast cancer. This evidence concerns the gene MKI67 and neoplasm.